Cargando…

Use of Databases for Early Recognition of Risk of Diabetic Complication by Analysis of Liver Enzymes in Type 2 Diabetes Mellitus

INTRODUCTION: Because of increasing prevalence of T2MD worldwide, it’s very important to recognize risk factors for diabetic complications, as soon as possible. Symptoms of complications appear a few or many years after tissue damage. So, it’s imperative to establish surveillance of diabetics with l...

Descripción completa

Detalles Bibliográficos
Autores principales: Malenica, Maja, Prnjavorac, Besim, Causevic, Adlija, Dujic, Tanja, Bego, Tamer, Semiz, Sabina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AVICENA, d.o.o., Sarajevo 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851514/
https://www.ncbi.nlm.nih.gov/pubmed/27147797
http://dx.doi.org/10.5455/aim.2016.24.90-93
_version_ 1782429829592776704
author Malenica, Maja
Prnjavorac, Besim
Causevic, Adlija
Dujic, Tanja
Bego, Tamer
Semiz, Sabina
author_facet Malenica, Maja
Prnjavorac, Besim
Causevic, Adlija
Dujic, Tanja
Bego, Tamer
Semiz, Sabina
author_sort Malenica, Maja
collection PubMed
description INTRODUCTION: Because of increasing prevalence of T2MD worldwide, it’s very important to recognize risk factors for diabetic complications, as soon as possible. Symptoms of complications appear a few or many years after tissue damage. So, it’s imperative to establish surveillance of diabetics with laboratory and other diagnostic procedures for early recognition of diabetic complications. Follow up of clinical curs of diabetes, by using databases of patients, provide possibility for permanent analysis of important laboratory parameters and any changes could be registered. Although an emerging evidence suggests a strong association of ALT (alanine aminotransferase) and γGT (gamma glutamyl transferase) activity with type 2 diabetes mellitus (T2DM), only a limited number of studies have analyzed the association of AST (aspartate aminotransferase), ALT, γGT, and ALP (alkaline phosphatase) activities in controlled T2DM. MATERIAL AND METHODS: Gender differences are of special interest in trying to follow diabetes progression and development of its complications. Here the activities of ALT, AST, γGT, ALP were analyzed as well as levels of glycosylated hemoglobin (HbA1c) and fasting plasma glucose (FPG) in 40 T2DM patients and 40 age-matched healthy subjects. Blood samples were collected from all participants in regular 3-months intervals up to 6 months period. Standard IFCC enzyme protocols were used to determine enzyme activities. RESULTS AND DISCUSSION: In first measured interval, significantly higher activities of ALT (p= 0,050) and glucose levels (p=0,045) were shown in male. A significant correlation was shown between ALT and AST activity with FPG and HbA1c levels in first and third measured interval. ALT activity was much higher in the group of patients with poor glycemia control. Average levels of activities of enzymes stay nearly in normal limits, but changes of enzymes activities should be recognized as soon as possible, earlier than tissue changes and diabetic complications become irreversible.
format Online
Article
Text
id pubmed-4851514
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher AVICENA, d.o.o., Sarajevo
record_format MEDLINE/PubMed
spelling pubmed-48515142016-05-04 Use of Databases for Early Recognition of Risk of Diabetic Complication by Analysis of Liver Enzymes in Type 2 Diabetes Mellitus Malenica, Maja Prnjavorac, Besim Causevic, Adlija Dujic, Tanja Bego, Tamer Semiz, Sabina Acta Inform Med Original Paper INTRODUCTION: Because of increasing prevalence of T2MD worldwide, it’s very important to recognize risk factors for diabetic complications, as soon as possible. Symptoms of complications appear a few or many years after tissue damage. So, it’s imperative to establish surveillance of diabetics with laboratory and other diagnostic procedures for early recognition of diabetic complications. Follow up of clinical curs of diabetes, by using databases of patients, provide possibility for permanent analysis of important laboratory parameters and any changes could be registered. Although an emerging evidence suggests a strong association of ALT (alanine aminotransferase) and γGT (gamma glutamyl transferase) activity with type 2 diabetes mellitus (T2DM), only a limited number of studies have analyzed the association of AST (aspartate aminotransferase), ALT, γGT, and ALP (alkaline phosphatase) activities in controlled T2DM. MATERIAL AND METHODS: Gender differences are of special interest in trying to follow diabetes progression and development of its complications. Here the activities of ALT, AST, γGT, ALP were analyzed as well as levels of glycosylated hemoglobin (HbA1c) and fasting plasma glucose (FPG) in 40 T2DM patients and 40 age-matched healthy subjects. Blood samples were collected from all participants in regular 3-months intervals up to 6 months period. Standard IFCC enzyme protocols were used to determine enzyme activities. RESULTS AND DISCUSSION: In first measured interval, significantly higher activities of ALT (p= 0,050) and glucose levels (p=0,045) were shown in male. A significant correlation was shown between ALT and AST activity with FPG and HbA1c levels in first and third measured interval. ALT activity was much higher in the group of patients with poor glycemia control. Average levels of activities of enzymes stay nearly in normal limits, but changes of enzymes activities should be recognized as soon as possible, earlier than tissue changes and diabetic complications become irreversible. AVICENA, d.o.o., Sarajevo 2016-04 2016-03-26 /pmc/articles/PMC4851514/ /pubmed/27147797 http://dx.doi.org/10.5455/aim.2016.24.90-93 Text en Copyright: © 2016 Maja Malenica, Adlija Causevic, T. Dujić, T. Bego, Besim Prnjavorac, S. Semiz http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Paper
Malenica, Maja
Prnjavorac, Besim
Causevic, Adlija
Dujic, Tanja
Bego, Tamer
Semiz, Sabina
Use of Databases for Early Recognition of Risk of Diabetic Complication by Analysis of Liver Enzymes in Type 2 Diabetes Mellitus
title Use of Databases for Early Recognition of Risk of Diabetic Complication by Analysis of Liver Enzymes in Type 2 Diabetes Mellitus
title_full Use of Databases for Early Recognition of Risk of Diabetic Complication by Analysis of Liver Enzymes in Type 2 Diabetes Mellitus
title_fullStr Use of Databases for Early Recognition of Risk of Diabetic Complication by Analysis of Liver Enzymes in Type 2 Diabetes Mellitus
title_full_unstemmed Use of Databases for Early Recognition of Risk of Diabetic Complication by Analysis of Liver Enzymes in Type 2 Diabetes Mellitus
title_short Use of Databases for Early Recognition of Risk of Diabetic Complication by Analysis of Liver Enzymes in Type 2 Diabetes Mellitus
title_sort use of databases for early recognition of risk of diabetic complication by analysis of liver enzymes in type 2 diabetes mellitus
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851514/
https://www.ncbi.nlm.nih.gov/pubmed/27147797
http://dx.doi.org/10.5455/aim.2016.24.90-93
work_keys_str_mv AT malenicamaja useofdatabasesforearlyrecognitionofriskofdiabeticcomplicationbyanalysisofliverenzymesintype2diabetesmellitus
AT prnjavoracbesim useofdatabasesforearlyrecognitionofriskofdiabeticcomplicationbyanalysisofliverenzymesintype2diabetesmellitus
AT causevicadlija useofdatabasesforearlyrecognitionofriskofdiabeticcomplicationbyanalysisofliverenzymesintype2diabetesmellitus
AT dujictanja useofdatabasesforearlyrecognitionofriskofdiabeticcomplicationbyanalysisofliverenzymesintype2diabetesmellitus
AT begotamer useofdatabasesforearlyrecognitionofriskofdiabeticcomplicationbyanalysisofliverenzymesintype2diabetesmellitus
AT semizsabina useofdatabasesforearlyrecognitionofriskofdiabeticcomplicationbyanalysisofliverenzymesintype2diabetesmellitus